Transient postprandial increase in intact circulating fibroblast growth factor-21 levels after Roux-en-Y gastric bypass: a randomized controlled clinical trial

BACKGROUND: Despite a consistent link between obesity and increased circulating levels of fibroblast growth factor-21 (FGF21), the effect of weight-loss interventions on FGF21 is not clear. We aimed to determine the short- and long-term effects of Roux-en-Y gastric bypass (RYGB) on intact plasma FGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Mette S., Søberg, Susanna, Schmidt, Julie B., Chenchar, Anne, Sjödin, Anders, Gillum, Matthew P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052976/
https://www.ncbi.nlm.nih.gov/pubmed/33954037
http://dx.doi.org/10.7717/peerj.11174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052976/
https://www.ncbi.nlm.nih.gov/pubmed/33954037
http://dx.doi.org/10.7717/peerj.11174

Ejemplares similares